LAVA Therapeutics N.V.
LVTX
$1.52
$0.010.66%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -35.29% | -29.62% | -19.88% | -24.60% | -22.78% |
| Total Receivables | -- | -- | -- | -25.94% | -73.73% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -13.54% | 31.40% | -34.11% | -14.53% | 27.91% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -2.94% | -- | -- |
| Total Current Assets | -32.91% | -27.81% | -19.82% | -24.44% | -23.92% |
|
|
|||||
| Total Current Assets | -32.91% | -27.81% | -19.82% | -24.44% | -23.92% |
| Net Property, Plant & Equipment | -97.81% | -40.56% | -41.27% | -38.60% | -46.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -93.75% | -62.89% | -71.47% | -65.03% | -58.38% |
| Total Assets | -34.39% | -28.18% | -20.50% | -24.92% | -24.69% |
|
|
|||||
| Total Accounts Payable | -65.68% | -55.78% | -38.78% | -70.00% | -17.88% |
| Total Accrued Expenses | -15.02% | 78.93% | 112.86% | 40.81% | -60.09% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -94.67% | -8.71% | 10.90% | 4.12% |
| Total Finance Division Other Current Liabilities | -- | -- | 106.30% | -- | -- |
| Total Other Current Liabilities | -- | -- | 106.30% | -- | -- |
| Total Current Liabilities | -60.23% | -20.43% | 20.89% | -26.76% | -36.81% |
|
|
|||||
| Total Current Liabilities | -60.23% | -20.43% | 20.89% | -26.76% | -36.81% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -98.45% | -80.72% | -75.56% | -77.58% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Liabilities | -17.80% | -6.28% | 5.52% | -10.74% | -15.76% |
|
|
|||||
| Common Stock & APIC | 9.18% | 8.97% | 1.53% | 0.01% | 0.01% |
| Retained Earnings | -19.38% | -20.19% | -16.76% | -19.04% | -16.34% |
| Treasury Stock & Other | -748.68% | -1,271.21% | -16.13% | 330.07% | 210.58% |
| Total Common Equity | -53.51% | -49.11% | -45.98% | -39.57% | -32.89% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -53.51% | -49.11% | -45.98% | -39.57% | -32.89% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -53.51% | -49.11% | -45.98% | -39.57% | -32.89% |
|
|
|||||